Abstract
NMDA receptors are a subclass of excitatory, ionotropic L-glutamate neurotransmitter receptors. They are.heteromeric, integral membrane proteins being formed by the assembly of the obligatory NR1 subunit together with modulatory NR2 subunits of which four different types, NR2A - NR2D, have been described. This results in a heterogenous population of receptor proteins with distinct pharmacological and biophysical properties thus yielding potential for the development of NMDA receptor subtype-selective therapeutic agents. Anti-NMDA receptor subunit antibodies have been generated and used in immunoprecipitation or immunoaffinity purification studies to determine the in vivo subunit complements of NMDA receptors. This article summarizes knowledge on the subunit compositions of NMDA receptors based on these approaches together with the current status of NMDA receptor subunit stoichiometry and hence quaternary structure. of native NMDA receptors.
Keywords: NMDA Receptors, immunoprecipitation, NR2A and NR2B
Current Drug Targets
Title: Subunit Characterization of NMDA Receptors
Volume: 2 Issue: 3
Author(s): F. Anne Stephenson
Affiliation:
Keywords: NMDA Receptors, immunoprecipitation, NR2A and NR2B
Abstract: NMDA receptors are a subclass of excitatory, ionotropic L-glutamate neurotransmitter receptors. They are.heteromeric, integral membrane proteins being formed by the assembly of the obligatory NR1 subunit together with modulatory NR2 subunits of which four different types, NR2A - NR2D, have been described. This results in a heterogenous population of receptor proteins with distinct pharmacological and biophysical properties thus yielding potential for the development of NMDA receptor subtype-selective therapeutic agents. Anti-NMDA receptor subunit antibodies have been generated and used in immunoprecipitation or immunoaffinity purification studies to determine the in vivo subunit complements of NMDA receptors. This article summarizes knowledge on the subunit compositions of NMDA receptors based on these approaches together with the current status of NMDA receptor subunit stoichiometry and hence quaternary structure. of native NMDA receptors.
Export Options
About this article
Cite this article as:
Stephenson Anne F., Subunit Characterization of NMDA Receptors, Current Drug Targets 2001; 2 (3) . https://dx.doi.org/10.2174/1389450013348461
DOI https://dx.doi.org/10.2174/1389450013348461 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modified LDL Immune Complexes and Cardiovascular Disease
Current Medicinal Chemistry Proteomic Analysis of Arabidopsis Leaves Subjected to Mechanical Wounding
Current Proteomics Editorial: (Thematic Issue: Natural Botanical Products Able to Improve Immune System Function)
Current Immunology Reviews (Discontinued) Mushrooms as a Source of Anti-Inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeting Central Plasticity: A New Direction of Finding Painkillers
Current Pharmaceutical Design Phytochemicals from Peanut (<i>Arachis hypogaea</i> L.) Skin Extract with Potential for Pharmacological Activity
Current Bioactive Compounds Paracetamol-Induced Stevens Johnson Syndrome and Cholestatic Hepatitis
Current Drug Safety Inflammation: A Link Between Hypertension and Atherosclerosis
Current Hypertension Reviews Development and Chemistry of Histamine H4 Receptor Ligands as Potential Modulators of Inflammatory and Allergic Responses
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Seasonal and Perennial Allergic Conjunctivitis
Recent Patents on Inflammation & Allergy Drug Discovery Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update
Current Vascular Pharmacology Transdermal Delivery of Methotrexate Loaded in Chitosan Nanoparticles to Treat Rheumatoid Arthritis
Current Drug Delivery Preface
Current Pharmaceutical Design Resolving Inflammation in Heart Failure: Novel Protective Lipid Mediators
Current Drug Targets Role of Adenosine Receptors in Rare Neurodegenerative Diseases with Motor Symptoms
Current Protein & Peptide Science Recent advances in the management of autoimmune myocarditis: insights from animal studies.
Current Pharmaceutical Design The Association of Chemotherapy and Radiotherapy: Biological Rationale
Current Drug Therapy Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A
Current Alzheimer Research Effects of Diet-Derived Molecules on the Tumor Microenvironment
Current Angiogenesis (Discontinued)